The diverse bioactivity of α-mangostin and its therapeutic implications

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Ovalle-Magallanes B, Eugenio-Pérez D, Pedraza-Chaverri J. Medicinal properties of mangosteen (Garcinia Mangostana L.): a comprehensive update. Food Chem. Toxicol. 109(Pt 1), 102–122 (2017).
  Medline CASGoogle Scholar
• 2. Aizat WM, Ahmad-Hashim FH, Syed Jaafar SN. Valorization of mangosteen, ‘The Queen of Fruits’, and new advances in postharvest and in food and engineering applications: a review. J. Adv. Res. 20(May 29), 61–70 (2019).
  Medline CASGoogle Scholar
• 3. Vemu B, Nauman MC, Veenstra JP, Johnson JJ. Structure activity relationship of xanthones for inhibition of cyclin dependent kinase 4 from mangosteen (Garcinia mangostana L.). Int. J. Nutr. 4(4), 38–45 (2019). •• Highlights the key functional groups responsible for α-mangostin's ability to inhibit CDK4.
  Medline CASGoogle Scholar
• 4. Wathoni N, Yuan Shan C, Yi Shan W et al. Characterization and antioxidant activity of pectin from Indonesian mangosteen (Garcinia mangostana L.) Rind. Heliyon. 5(8), e02299 (2019).
  MedlineGoogle Scholar
• 5. Suksamrarn S, Komutiban O, Ratananukul P et al. Cytotoxic prenylated xanthones from the young fruit of Garcinia mangostana. Chem. Pharm Bull. (Tokyo). 54(3), 301–305 (2006).
  Medline CASGoogle Scholar
• 6. Rana MN, Tangpong J, Rahman MA. Xanthones protects lead-induced chronic kidney disease (CKD) via activating Nrf-2 and modulating NF-κB, MAPK pathway. Biochem. Biophys. Rep. 21, 100718 (2020).
  MedlineGoogle Scholar
• 7. Mohamed GA, Al-Abd AM, El-halawany AM et al. New xanthones and cytotoxic constituents from Garcinia mangostana fruit hulls against human hepatocellular, breast, and colorectal cancer cell lines. J. Ethnopharmacol. 198, 302–312 (2017).
  Medline CASGoogle Scholar
• 8. Shan T, Ma Q, Guo K et al. Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugs. Curr. Mol. Med. 11(8), 666–677 (2011).
  Medline CASGoogle Scholar
• 9. Elsaid Ali AA. Development and validation of analytical method by RP-HPLC for quantification of alpha-mangostin encapsulated in PLGA microspheres. J. Anal. Bioanal. Tech. 3(7), 1–5 (2012).
  Google Scholar
• 10. Arunrattiyakorn P, Suksamrarn S, Suwannasai N, Kanzaki H. Microbial metabolism of α-mangostin isolated from Garcinia mangostana L. Phytochemistry. 72(8), 730–734 (2011).
  Medline CASGoogle Scholar
• 11. W. Ueber Das Mangostin. Justus Liebigs Ann. Chem. 93(1), 83–88 (1855).
  Google Scholar
• 12. Li G, Thomas S, Johnson JJ. Polyphenols from the mangosteen (Garcinia mangostana) fruit for breast and prostate cancer. Front. Pharmacol. 4(80), 1–4 (2013).
  MedlineGoogle Scholar
• 13. Yates P, Stout GH. The structure of mangostin. J. Am. Chem. Soc. 80(7), 1691–1700 (1958).
  CASGoogle Scholar
• 14. Ding YY, Luan JJ, Fan Y et al. α-Mangostin reduced the viability of A594 cells in vitro by provoking reactive oxygen species production through downregulation of NAMPT/NAD. Cell Stress Chaperones. 25(1), 163–172 (2020). • Describes how α-mangostin downregulates the NAMPT/NAD signaling pathway which alters ROS production leading to antitumor activity.
  Medline CASGoogle Scholar
• 15. Li RS, Xu GH, Cao J et al. Alpha-mangostin ameliorates bleomycin-induced pulmonary fibrosis in mice partly through activating adenosine 5′-monophosphate-activated protein kinase. Front. Pharmacol. 10(Nov 13), 1305 (2019).
  Medline CASGoogle Scholar
• 16. Liu Q, Li D, Wang A et al. Nitric oxide inhibitory xanthones from the pericarps of Garcinia mangostana. Phytochemistry. 131(Nov), 115–123 (2016).
  Medline CASGoogle Scholar
• 17. Markowicz J, Uram Ł, Sobich J, Mangiardi L, Maj P, Rode W. Antitumor and anti-nematode activities of α-mangostin. Eur. J. Pharmacol. 863(Nov 15), 172678 (2019).
  Medline CASGoogle Scholar
• 18. Kashyap D, Tuli HS, Yerer MB et al. Natural product-based nanoformulations for cancer therapy: opportunities and challenges. Semin. Cancer Biol. 69(Feb), 5–23 (2021).
  Medline CASGoogle Scholar
• 19. Cragg GM, Pezzuto JM. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med. Princ. Pract. 25(Suppl. 2), 41–59 (2016).
  MedlineGoogle Scholar
• 20. Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20(3), 200–216 (2021).
  Medline CASGoogle Scholar
• 21. Amawi H, Ashby CR, Tiwari AK. Cancer chemoprevention through dietary flavonoids: what’s limiting? Chin. J. Cancer. 36(1), 50 (2017).
  MedlineGoogle Scholar
• 22. Wu J, Dai J, Zhang Y et al. Synthesis of novel xanthone analogues and their growth inhibitory activity against human lung cancer A549 cells. Drug Des. Devel. Ther. 13, 4239–4246 (2019).
  Medline CASGoogle Scholar
• 23. Cai N, Xie SJ, Qiu DB et al. Potential effects of α-mangostin in the prevention and treatment of hepatocellular carcinoma. J. Funct. Foods. 11(1), 309–318 (2016).
  Google Scholar
• 24. Lee CH, Ying TH, Chiou HL et al. Alpha-mangostin induces apoptosis through activation of reactive oxygen species and ASK1/P38 signaling pathway in cervical cancer cells. Oncotarget. 8(29), 47425–47439 (2017).
  MedlineGoogle Scholar
• 25. Chien HJ, Ying TH, Hsieh SC et al. α-Mangostin attenuates stemness and enhances cisplatin-induced cell death in cervical cancer stem-like cells through induction of mitochondrial-mediated apoptosis. J. Cell. Physiol. 235(7–8), 5590–5601 (2020).
  Medline CASGoogle Scholar
• 26. Chen CM, Hsieh SC, Lin CL et al. Alpha-mangostin suppresses the metastasis of human renal carcinoma cells by targeting MEK/ERK expression and MMP-9 transcription activity. Cell. Physiol. Biochem. 44(4), 1460–1470 (2017).
  Medline CASGoogle Scholar
• 27. Kwak HH, Kim IR, Kim HJ et al. α-mangostin induces apoptosis and cell cycle arrest in oral squamous cell carcinoma cell. Evid. Based Complement. Alternat. Med. 2016, 5352412 (2016).
  MedlineGoogle Scholar
• 28. Hsieh SC, Huang MH, Cheng CW et al. α-mangostin induces mitochondrial dependent apoptosis in human hepatoma SK-Hep-1 cells through inhibition of P38 MAPK pathway. Apoptosis. 18(12), 1548–1560 (2013).
  Medline CASGoogle Scholar
• 29. Kritsanawong S, Innajak S, Imoto M, Watanapokasin R. Antiproliferative and apoptosis induction of α-mangostin in T47D breast cancer cells. Int. J. Oncol. 48(5), 2155–2165 (2016).
  Medline CASGoogle Scholar
• 30. Lemos A, Leão M, Soares J et al. Medicinal chemistry strategies to disrupt the P53–MDM2/MDMX interaction. Med. Res. Rev. 36(5), 789–844 (2016).
  Medline CASGoogle Scholar
• 31. Wong RSY. Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Cancer Res. 30(1), 87 (2011).
  Medline CASGoogle Scholar
• 32. Plati J, Bucur O, Khosravi-Far R. Apoptotic cell signaling in cancer progression and therapy. Integr. Biol. 3(4), 279–296 (2011).
  CASGoogle Scholar
• 33. Gerl R, Vaux DL. Apoptosis in the development and treatment of cancer. Carcinogenesis. 26(2), 263–270 (2005).
  Medline CASGoogle Scholar
• 34. Mohammad RM, Muqbil I, Lowe L et al. Broad targeting of resistance to apoptosis in cancer. Semin. Cancer Biol. 35(Suppl.), S78–S103 (2015).
  MedlineGoogle Scholar
• 35. Wang JJ, Zhang W, Sanderson BJS. Altered MRNA expression related to the apoptotic effect of three xanthones on human melanoma SK-MEL-28 cell line. BioMed Res. Int. 2013, 715603 (2013).
  MedlineGoogle Scholar
• 36. O’Brien MA, Kirby R. Apoptosis: a review of pro-apoptotic and anti-apoptotic pathways and dysregulation in disease. J. Vet. Emerg. Crit. Care. 18(6), 572–585 (2008).
  Google Scholar
• 37. Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell Biol. 20(3), 175–193 (2019).
  Medline CASGoogle Scholar
• 38. Pérez-Rojas JM, González-Macías R, González-Cortes J, Jurado R, Pedraza-Chaverri J, García-López P. Synergic effect of α-mangostin on the cytotoxicity of cisplatin in a cervical cancer model. Oxid. Med. Cell. Longev. 2016, 7981397 (2016).
  MedlineGoogle Scholar
• 39. Zhang C, Yu G, Shen Y. The naturally occurring xanthone α-mangostin induces ROS-mediated cytotoxicity in non-small scale lung cancer cells. Saudi J. Biol. Sci. 25(6), 1090–1095 (2018).
  Medline CASGoogle Scholar
• 40. Wudtiwai B, Pitchakarn P, Banjerdpongchai R. Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells. Toxicol. In Vitro. 53(Dec), 222–232 (2018). • Describes α-mangostin’s ability to disrupt anoikis-resistance by inhibiting AKT and ERK signaling pathways.
  Medline CASGoogle Scholar
• 41. Yamanoi K, Matsumura N, Murphy SK et al. Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer. Oncotarget. 7(30), 4762047636 (2016).
  Google Scholar
• 42. Cao Z, Livas T, Kyprianou N. Anoikis and EMT: lethal ‘liaisons’ during cancer progression. Physiol. Behav. 21(3–4), 155–168 (2016).
  Google Scholar
• 43. Yeong KY, Khaw KY, Takahashi Y, Itoh Y, Murugaiyah V, Suzuki T. Discovery of gamma-mangostin from Garcinia mangostana as a potent and selective natural SIRT2 inhibitor. Bioorganic Chem. 94(Jan), 103403 (2020).
  Medline CASGoogle Scholar
• 44. Di Fruscia P, Ho K, Laohasinnarong S et al. The discovery of novel 10,11-dihydro-5h-dibenz[b,f]azepine SIRT2 inhibitors. MedChemComm. 3, 373–378 (2012).
  Google Scholar
• 45. Jing H, Hu J, He B et al. A SIRT2-selective inhibitor promotes c-Myc oncoprotein degradation and exhibits broad anticancer activity. Cancer Cell. 29(3), 297–310 (2016).
  Medline CASGoogle Scholar
• 46. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 144(5), 646–674 (2011).
  Medline CASGoogle Scholar
• 47. Gandalovičová A, Rosel D, Fernandes M et al. Migrastatics – anti-metastatic and anti-invasion drugs: promises and challenges. Trends Cancer. 3(6), 391–406 (2017).
  Medline CASGoogle Scholar
• 48. Wang JJ, Sanderson BJS, Zhang W. Significant anti-invasive activities of α-mangostin from the mangosteen pericarp on two human skin cancer cell lines. Anticancer Res. 32(9), 3805–3816 (2012).
  Medline CASGoogle Scholar
• 49. Hung SH, Shen KH, Wu CH et al. α-Mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway. J. Agric. Food Chem. 57(4), 1291–1298 (2009).
  Medline CASGoogle Scholar
• 50. Lee YB, Ko KC, Shi MD et al. Alpha-mangostin, a novel dietary xanthone, suppresses TPA-mediated MMP-2 and MMP-9 expressions through the ERK signaling pathway in MCF-7 human breast adenocarcinoma cells. J. Food Sci. 75(1), H13–H23 (2010).
  Medline CASGoogle Scholar
• 51. Shih YW, Chien ST, Chen PS et al. α-Mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expressions via Avβ3 integrin/FAK/ERK and NF-κB signaling pathway in human lung adenocarcinoma A549 cells. Cell Biochem. Biophys. 58(1), 31–44 (2010).
  Medline CASGoogle Scholar
• 52. Han C, Li Z, Hou J et al. Bioactivity evaluation of natural product α-mangostin as a novel xanthone-based lysine-specific demethylase 1 inhibitor to against tumor metastasis. Bioorganic Chem. 76(Feb), 415–419 (2018).
  Medline CASGoogle Scholar
• 53. Beninati S, Oliverio S, Cordella M et al. Inhibition of cell proliferation, migration and invasion of B16-F10 melanoma cells by α-mangostin. Biochem. Biophys. Res. Commun. 450(4), 1512–1517 (2014).
  Medline CASGoogle Scholar
• 54. Mohan S, Syam S, Abdelwahab SI, Thangavel N. An anti-inflammatory molecular mechanism of action of α-mangostin, the major xanthone from the pericarp of Garcinia mangostana: an in silico, in vitro and in vivo approach. Food Funct. 9(7), 3860–3871 (2018). • The mechanism of α-mangostin's anti-inflammatory effect is explained in detail.
  Medline CASGoogle Scholar
• 55. Pan T, Wu D, Cai N et al. Alpha-mangostin protects rat articular chondrocytes against IL-1β-induced inflammation and slows the progression of osteoarthritis in a rat model. Int. Immunopharmacol. 52(Nov), 34–43 (2017).
  Medline CASGoogle Scholar
• 56. Herrera-Aco DR, Medina-Campos ON, Pedraza-Chaverri J et al. Alpha-mangostin: anti-inflammatory and antioxidant effects on established collagen-induced arthritis in DBA/1J mice. Food Chem. Toxicol. 124(Feb), 300–315 (2019).
  Medline CASGoogle Scholar
• 57. You BH, Chae HS, Song J et al. α-mangostin ameliorates dextran sulfate sodium-induced colitis through inhibition of NF-κB and MAPK pathways. Int. Immunopharmacol. 49, 212–221 (2017).
  Medline CASGoogle Scholar
• 58. Gutierrez-Orozco F, Thomas-Ahner JM, Berman-Booty LD et al. Dietary α-mangostin, a xanthone from mangosteen fruit, exacerbates experimental colitis and promotes dysbiosis in mice. Mol. Nutr. Food Res. 58(6), 1226–1238 (2014).
  Medline CASGoogle Scholar
• 59. Cai Y, Zhu L, Zhang F et al. Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs). Mol. Pharm. 10(6), 2237–2247 (2013).
  Medline CASGoogle Scholar
• 60. Sundarakrishnan A, Zukas H, Coburn J et al. Bioengineered in vitro tissue model of fibroblast activation for modeling pulmonary fibrosis. ACS Biomater. Sci. Eng. 5(5), 2417–2429 (2019).
  Medline CASGoogle Scholar
• 61. Mahabusarakam W, Proudfoot J, Taylor W, Croft K. Inhibition of lipoprotein oxidation by prenylated xanthones derived from mangostin. Free Radic. Res. 33(5), 643–659 (2000). •• Highlights the key functional groups of α-mangostin responsible for its antioxidant activity.
  Medline CASGoogle Scholar
• 62. Kondo M, Zhang L, Ji H, Kou Y, Ou B. Bioavailability and antioxidant effects of a xanthone-rich mangosteen (Garcinia mangostana) product in humans. J. Agric. Food Chem. 57(19), 8788–8792 (2009).
  Medline CASGoogle Scholar
• 63. Ibrahim MY, Hashim NM, Mariod AA et al. α-Mangostin from Garcinia mangostana linn: an updated review of its pharmacological properties. Arab. J. Chem. 9(3), 317–329 (2016).
  CASGoogle Scholar
• 64. Fang Y, Su T, Qiu X et al. Protective effect of alpha-mangostin against oxidative stress induced-retinal cell death. Sci. Rep. 6(Feb 18), 21018 (2016).
  Medline CASGoogle Scholar
• 65. Lei J, Huo X, Duan W et al. α-mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. Cancer Lett. 347(1), 129–138 (2014).
  Medline CASGoogle Scholar
• 66. Giannoni E, Bianchini F, Calorini L, Chiarugi P. Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid. Redox Signal. 14(12), 2361–2371 (2011).
  Medline CASGoogle Scholar
• 67. Pérez-Rojas JM, Cruz C, García-López P et al. Renoprotection by alpha-mangostin is related to the attenuation in renal oxidative/nitrosative stress induced by cisplatin nephrotoxicity. Free Radic. Res. 43(11), 1122–1132 (2009). • The renoprotective mechanism of action for α-mangostin is discussed in detail.
  Medline CASGoogle Scholar
• 68. Golestaneh N, Chu Y, Xiao YY et al. Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration. Cell Death Dis. 8(1), e2537 (2017).
  Medline CASGoogle Scholar
• 69. Velez G, Machlab DA, Tang PH et al. Proteomic analysis of the human retina reveals region-specific susceptibilities to metabolic- and oxidative stress-related diseases. PLoS ONE. 13(2), e0193250 (2018).
  MedlineGoogle Scholar
• 70. Koh JJ, Qiu S, Zou H et al. Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting. Biochim. Biophys. Acta - Biomembr. 1828(2), 834–844 (2013).
  Medline CASGoogle Scholar
• 71. Widyarman A, Lay S, Wendhita I et al. Indonesian mangosteen fruit (Garcinia mangostana L.) peel extract inhibits Streptococcus mutans and Porphyromonas gingivalis in biofilms in vitro. Contemp. Clin. Dent. 10(1), 123–128 (2019).
  Medline CASGoogle Scholar
• 72. Sakagami Y, Iinuma M, Piyasena KGNP, Dharmaratne HRW. Antibacterial activity of α-mangostin against vancomycin resistant enterococci (VRE) and synergism with antibiotics. Phytomedicine. 12(3), 203–208 (2005).
  Medline CASGoogle Scholar
• 73. Larsuprom L, Rungroj N, Lekcharoensuk C et al. In vitro antibacterial activity of mangosteen (Garcinia mangostana Linn.) crude extract against Staphylococcus pseudintermedius isolates from canine pyoderma. Vet. Dermatol. 30(6), 487–e145 (2019).
  MedlineGoogle Scholar
• 74. Sivaranjani M, Leskinen K, Aravindraja C et al. Deciphering the antibacterial mode of action of alpha-mangostin on Staphylococcus epidermidis RP62A through an integrated transcriptomic and proteomic approach. Front. Microbiol. 10(Feb 6), 150 (2019). • The possible anti-bacterial mechanisms of action of α-mangostin are described, while also discussing a novel pathway through which it avoids developing resistance.
  MedlineGoogle Scholar
• 75. Nguyen PTM, Marquis RE. Antimicrobial actions of α-mangostin against oral streptococci. Can. J. Microbiol. 57(3), 217–225 (2011).
  Medline CASGoogle Scholar
• 76. Sivaranjani M, Prakash M, Gowrishankar S et al. In vitro activity of alpha-mangostin in killing and eradicating Staphylococcus epidermidis RP62A biofilms. Appl. Microbiol. Biotechnol. 101(8), 3349–3359 (2017).
  Medline CASGoogle Scholar
• 77. Kim HM, Kim YM, Huh JH et al. α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2. PLoS ONE. 12(6), e0179204 (2017).
  MedlineGoogle Scholar
• 78. Tousian Shandiz H, Razavi BM, Hosseinzadeh H. Review of Garcinia mangostana and its xanthones in metabolic syndrome and related complications. Phytother. Res. 31(8), 1173–1182 (2017).
  MedlineGoogle Scholar
• 79. Tsai SY, Chung PC, Owaga EE et al. Alpha-mangostin from mangosteen (Garcinia mangostana Linn.) pericarp extract reduces high fat-diet induced hepatic steatosis in rats by regulating mitochondria function and apoptosis. Nutr. Metab. 13(Dec 1), 88 (2016).
  Google Scholar
• 80. Li D, Liu Q, Lu X et al. α-mangostin remodels visceral adipose tissue inflammation to ameliorate age-related metabolic disorders in mice. Aging. 11(23), 11084–11110 (2019).
  Medline CASGoogle Scholar
• 81. Chae HS, Kim EY, Han L et al. Xanthones with pancreatic lipase inhibitory activity from the pericarps of Garcinia mangostana L. (Guttiferae). Eur. J. Lipid Sci. Technol. 118(9), 1416–1421 (2016).
  CASGoogle Scholar
• 82. Watanabe M, Gangitano E, Francomano D et al. Mangosteen extract shows a potent insulin sensitizing effect in obese female patients: a prospective randomized controlled pilot study. Nutrients. 10(5), 586 (2018).
  Google Scholar
• 83. Quan X, Wang Y, Ma X et al. α-mangostin induces apoptosis and suppresses differentiation of 3T3-L1 cells via inhibiting fatty acid synthase. PLoS ONE. 7(3), e33376 (2012).
  Medline CASGoogle Scholar
• 84. Taher M, Mohamed Amiroudine MZA, Tengku Zakaria TMFS et al. α-mangostin improves glucose uptake and inhibits adipocytes differentiation in 3T3-L1 cells via PPAR γ, GLUT4, and leptin expressions. Evid. Based Complement. Alternat. Med. 2015, 740238 (2015).
  MedlineGoogle Scholar
• 85. Chae HS, Kim YM, Bae JK et al. Mangosteen extract attenuates the metabolic disorders of high-fat-fed mice by activating AMPK. J. Med. Food. 19(2), 148–154 (2015).
  MedlineGoogle Scholar
• 86. Karim N, Rahman MA, Changlek S, Tangpong J. Short-time administration of xanthone from Garcinia mangostana fruit pericarp attenuates the hepatotoxicity and renotoxicity of Type II diabetes mice. J. Am. Coll. Nutr. 39(6), 501–510 (2019).
  MedlineGoogle Scholar
• 87. Kumar V, Bhatt PC, Kaithwas G et al. α-Mangostin mediated pharmacological modulation of hepatic carbohydrate metabolism in diabetes induced Wistar rat. Beni-Suef Univ. J. Basic Appl. Sci. 5(3), 255–276 (2016).
  Google Scholar
• 88. Nain P, Saini V, Sharma S, Nain J. Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced Type-2 diabetes mellitus (T2DM) rats. J. Ethnopharmacol. 142(1), 65–71 (2012).
  Medline CASGoogle Scholar
• 89. Lee D, Kim YM, Jung K et al. Alpha-mangostin improves insulin secretion and protects INS-1 cells from streptozotocin-induced damage. Int. J. Mol. Sci. 19(5), 1484 (2018). • The antidiabetic mechanism of action of α-mangostin is elucidated.
  Google Scholar
• 90. Taher M, Tg Zakaria TMFS, Susanti D, Zakaria ZA. Hypoglycaemic activity of ethanolic extract of Garcinia mangostana Linn. in normoglycaemic and streptozotocin-induced diabetic rats. BMC Complement. Altern. Med. 16(May 21), 135 (2016).
  MedlineGoogle Scholar
• 91. Shagufta, Ahmad I. Recent insight into the biological activities of synthetic xanthone derivatives. Eur. J. Med. Chem. 116(Jun 30), 267–280 (2016).
  Medline CASGoogle Scholar
• 92. Wathoni N, Rusdin A, Motoyama K, Joni IM, Lesmana R, Muchtaridi M. Nanoparticle drug delivery systems for α-mangostin. Nanotechnol. Sci. Appl. 13(Apr 1), 23–36 (2020).
  Medline CASGoogle Scholar
• 93. Asasutjarit R, Meesomboon T, Adulheem P et al. Physicochemical properties of alpha-mangostin loaded nanomeulsions prepared by ultrasonication technique. Heliyon. 5(9), e02465 (2019).
  MedlineGoogle Scholar
• 94. Aisha AF, Ismail Z, Abu-Salah KM, Majid AM. Solid dispersions of α-mangostin improve its aqueous solubility through self-assembly of nanomicelles. J. Pharm. Sci. 101(2), 815–825 (2012).
  Medline CASGoogle Scholar
• 95. Li L, Brunner I, Han AR et al. Pharmacokinetics of α-mangostin in rats after intravenous and oral application. Mol. Nutr. Food Res. 55(S1), S67–S74 (2011).
  Medline CASGoogle Scholar
• 96. Kittipaspallop W, Taepavarapruk P, Chanchao C, Pimtong W. Acute toxicity and teratogenicity of α-mangostin in zebrafish embryos. Exp. Biol. Med. 243(15–16), 1212–1219 (2018).
  CASGoogle Scholar